Relationships between serum magnesium levels and clinical background factors in patients with mood disorders

Psychiatry and Clinical Neurosciences

Volumn 56, Issue 5, 2002, Pages 509-514

  Imada, Yuzo ^a   Yoshioka, Shin Ichi ^a   Ueda, Toshiyuki ^a   Katayama, Seiji ^a   Kuno, Yoshie ^a   Kawahara, Ryuzo ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Clinical background; Magnesium; Mood disorder; Psychotropic drug

Indexed keywords

MAGNESIUM; PSYCHOTROPIC AGENT;

ADULT; AFFECTIVE NEUROSIS; AGE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; SEX DIFFERENCE;

ADULT; DEPRESSIVE DISORDER; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; MOOD DISORDERS; PSYCHOTROPIC DRUGS;

EID: 0036791659     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.2002.01046.x     Document Type: Article

References (30)

1. Cundall RL, Moir ATB, Martin MJ. Plasma and erythrocyte magnesium levels in affective disorders. Lancet 1972; ii: 281.
2. Dunner DL, Meltzer HL, Schreiner HC, Feigelson JL. Plasma and erythrocyte magnesium levels in patients with primary affective disorder during chronic lithium treatment. Acta Psychiatr. Scand. 1975; 51: 104-109.
3. Frazer A, Ramsey TA, Swann A et al. Plasma and erythrocyte electrolytes in affective disorders. J. Affect. Disord. 1983; 5: 103-113.
4. Kamei K, Tabata O, Muneoka K, Muraoka S-I, Tomiyoshi R, Takigawa M. Electrolytes in erythrocytes of patients with depressive disorders. Psychiatry Clin. Neurosci. 1998; 52: 529-533.
5. Widmer J, Feray JC, Bovier P etal. Sodium-magnesium exchange in erythrocyte membranes from patients with affective disorders. Neuropsychobiology 1995; 32: 13-18.
6. Widmer J, Henrotte J-G, Raffin Y, Bovier P, Hilleret H, Gaillard J-M. Relationship between erythrocyte magnesium, plasma electrolytes and cortisol, and intensity of symptoms in major depressed patients. J. Affect. Disord. 1995; 34: 201-209.
7. Karege F, Bovier P, Widmer J, Gaillard J-M, Tissot R. Decrease in epinephrine-induced attenutaion of platelet adenylate cyclase activity in depressed patients: Relation with plasma electrolytes. Neuropsychobiology 1992; 26: 129-135.
8. Karege F, Bovier P, Widmer J, Gaillard J-M, Tissot R. Platelet membrane alpha2-adrenergic receptors in depression. Psychiatry Res. 1992; 43: 243-252.
9. Linder J, Brismar K, Beck-Friis J, Sääf J, Wetterberg L. Calcium and magnesium concentrations in affective disorder: Difference between plasma and serum in relation to symptoms. Acta Psychiatr. Scand. 1989; 80: 527-537.
10. Cade JFJ. A significant elevation of plasma magnesium levels in schizophrenia and depressive states. Med. J. Aust. 1964; 1: 195-196.
11. Ramsey TA, Frazer A, Mendels J. Plasma and erythrocyte cations in affective illness. Neuropsychobiology 1979; 5: 1-10.
12. Widmer J, Bovier P, Karege F et al. Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months. Neuropsychobiology 1992; 26: 173-179.
13. Widmer J, Mouthon D, Raffin Y et al. Weak association between blood sodium, potasium, and calcium and intensity of symptoms in major depressed patients. Neuropsychobiology 1997; 36: 164-171.
14. Widmer J, Stella N, Raffin Y et al. Blood magnesium, potassium, sodium, calcium and cortisol in drug-free depressed patients. Magnes. Res. 1993; 6: 33-41.
15. 2+ ratio in major depressive disorder. Neuropsychobiology 1996; 34: 26-28.
16. Frizel D, Coppen A, Marks V. Plasma magnesium and calcium in depression. Br. J. Psychiatry 1969; 115: 1375-1377.
17. Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 1990; 23: 79-81.
18. Pliszka SR, Rogeness GA. Calcium and magnesium in children with schizophrenia and major depression. Biol. Psychiatry 1984; 19: 871-876.
19. Rasmussen HH, Mortensen PB, Jensen IW. Depression and magnesium deficiency. Int. J. Psychiatry Med. 1989; 19: 57-63.
20. Mellerup ET, Lauritsen B, Dam H, Rafaelsen OJ. Lithium effects on diurnal rhythm of calcium, magnesium, and phosphate metabolism in manic-melancholic disorder. Acta Psychiatr. Scand. 1976; 53: 360-370.
21. Carman JS, Post RM, Teplitz TA, Goodwin FK. Divalent cations in predicting antidepressant response to lithium. Lancet 1974; ii: 1454.
22. Chouinard G, Beauclair L, Geiser R, Etienne P. A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 1990; 14: 171-180.
23. Mann CK, Yoe JH. Spectrophotometric determination of magnesium with sodium 1-azo-2-hydroxy-3-(2,4-dimethylcarboxanilido) naphthalene-1í-(2-hydroxybenzene-5-sulfate). Anal. Chem. 1956; 28: 202-205.
24. Hasey GM, D'Alessandro E, Cooke RG, Warsh JJ. The interface between thyroid activity, magnesium, and depression: A pilot study. Biol. Psychiatry 1993; 33: 133-135.
25. Herzberg L, Bold AM. Sex difference in mean serum-magnesium levels in depression. Lancet 1972; i: 1128-1129.
26. Herzberg L, Bold AW. A sex difference in mean serum magnesium levels in depression. Clin. Chim. Acta 1972; 39: 229-231.
27. Herzberg L, Herzberg B. Mood change and magnesium. J. Nerv. Ment. Dis. 1977; 165: 423-426.
28. Carney MWP, Sheffield BF. Sex difference in mean-serum magnesium levels in depression. Lancet 1972; i: 1287.
29. Naylor GJ, Fleming LW, Stewart WK, McNamee HB, Le Poidevin D. Plasma magnesium and calcium levels in depressive psychosis. Br. J. Psychiatry 1972; 120: 683-684.
30. Rybakowski J, Szajnerman Z. Lithium-magnesium relationship in red blood cells during lithium prophylaxis. Pharmakopsychiatr. Neuropsychopahrmakol. 1976; 9: 242-246.